| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -173,231 | -111,774 |
| Depreciation | 13,784 | 9,197 |
| Stock-based compensation | 45,578 | 31,532 |
| Loss on disposal of long-lived assets | -8 | -8 |
| Non-cash lease impairment expense | 1,910 | 1,910 |
| Settlement of derivative contracts | 0 | 0 |
| Amortization of operating lease right-of-use asset | 6,021 | 4,069 |
| Prepaid expenses and other current assets | -172 | -108 |
| Other assets | -53 | -68 |
| Accounts payable | 6,444 | 1,129 |
| Accrued and other current liabilities | 9,275 | 3,636 |
| Operating lease liability | -8,144 | -5,133 |
| Long-term deposit | 1,500 | 1,500 |
| Net cash used in operating activities | -96,630 | -63,750 |
| Purchase of property and equipment | 463 | 403 |
| Deposits on property and equipment | 0 | - |
| Settlement of derivative contracts | 0 | 0 |
| Net cash used in investing activities | -463 | -403 |
| Proceeds from stock option exercises | 975 | 162 |
| Proceeds from issuance of common stock pursuant to espp | 82 | 82 |
| Net cash provided by financing activities | 1,057 | 244 |
| Net (decrease) in cash, cash equivalents and restricted cash | -96,036 | -63,909 |
| Cash and cash equivalents at beginning of period | 174,258 | - |
| Cash and cash equivalents at end of period | 78,222 | - |
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)